Article info
Letter
Impaired long-term immune protection following pneumococcal 13-valent/23-valent polysaccharide vaccine in systemic lupus erythematosus (SLE)
- Correspondence to Professor Karim Sacre, Department of Internal Medicine, Bichat Hospital, APHP, Paris 75018, France; karim.sacre{at}bch.aphp.fr
Citation
Impaired long-term immune protection following pneumococcal 13-valent/23-valent polysaccharide vaccine in systemic lupus erythematosus (SLE)
Publication history
- Received December 4, 2017
- Revised February 5, 2018
- Accepted February 5, 2018
- First published February 14, 2018.
Online issue publication
April 20, 2023
Article Versions
- Previous version (1 July 2020).
- You are viewing the most recent version of this article.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.